Mesothelioma Treatment Section
1515 North Campbell Avenue
Tucson, Arizona 85724
The Arizona Cancer Center is a National Cancer Institute-Designated comprehensive cancer center at the University of Arizona Health Sciences Center in Tucson. This is Arizona’s first comprehensive cancer center. Because the Arizona Cancer Center is a comprehensive center, this means that the center not only focuses on basic science research and clinical (patient-oriented) research, but it also focuses on control, prevention, and population sciences. Comprehensive centers also serve their communities and regions, through education, information activities, and outreach. Comprehensive status is the highest possible ranking by the National Cancer Institute.
In addition to mesothelioma, the Arizona Cancer Center treats numerous types of cancer such as breast cancer, cervical cancer, colorectal cancer, endomentrial cancer, esophageal cancer, stomach cancer, lung cancer, oral cancer, ovarian cancer, prostate cancer, digestive tract cancer, and skin cancer, as well as colon cancer, leukemia, lymphoma, and myeloma.
The center highlights its Cancer Prevention and Control Program, its Cancer Prevention and Control Research, its Cancer Prevention Guidelines and also offers numerous treatment options, typically using a combination of strategies. The treatment options available at the Arizona Cancer Center are surgery (to remove cancerous or non-cancerous tumors), drug therapy (chemotherapy and biological therapy), radiation therapy (intraoperative, radiosurgery, and radioactive seed implants) blood and marrow transplantation (BMT), and gene therapy.
The Arizona Cancer Center also offers new cancer drugs that are in the process of being tested for their effectiveness. Cancer patients interested in trying these new drugs can participate in a clinical trial. as well as new cancer drugs that are being tested for their effectiveness. In addition to testing new drugs, clinical trials also test new combinations of drugs, or new anticancer treatment strategies, including gene therapy, immunotherapy, and radiosurgery.
The Arizona Cancer Center receives support from corporations, organizations, small groups, and individuals as well as support through grants. The Arizona Cancer has received five major grants in its lifetime. Recently, the Arizona Cancer Center’s Gastrointestinal (GI) Cancer Program received one of the five — a $12 million Specialized Program of Research Excellence (SPORE) grant from the National Cancer Institute (NCI). The Arizona Cancer Center is among a lucky few to receive this grant. Only four other institutions across the country, have been awarded a GI SPORE grant. They are: Harvard, Johns Hopkins, the University of North Carolina, and Vanderbilt University. The GI SPORE is the largest new grant to be funded in the past ten years.